Evidence map›Paper›PMID 18287565›Full record

ReviewRNA (New York, N.Y.)2008

Hammerhead redux: does the new structure fit the old biochemical data?

Jennifer A Nelson, Olke C Uhlenbeck

Open access · bronzeAbstract readComparative StudyReview
In one paragraph

Review in RNA (New York, N.Y.), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Surface-Accelerated String Method for Locating Minimum Free Energy Paths.Journal of chemical theory and computation · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. The hammerhead ribozyme: structure, catalysis, and gene regulation.Progress in molecular biology and translational science · 2013
    Review
  20. The ubiquitous hammerhead ribozyme.RNA (New York, N.Y.) · 2012
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jennifer A NelsonDepartment of Biochemistry, Molecular Biology and Cell Biology, Northwestern University, Evanston, Illinois 60208, USA.
Olke C Uhlenbeck
Northwestern University · US

Funding

EXTRAMULAR RESEARCH FACILITIES CONSTRUCTIONC06RR018850 · NCRR · NORTHWESTERN UNIVERSITY · PI LINZER, DANIEL I · 2003 to 2003
$4.0M
STRUCTURE/FUNCTION OF RIBONUCLEIC ACIDR01GM036944 · NIGMS · UNIVERSITY OF COLORADO AT BOULDER · PI UHLENBECK, OLKE C · 1986 to 2009
$3.4M
NCRR NIH HHS 1C06RR018850-01NCRR NIH HHS C06 RR018850NIGMS NIH HHS R01 GM036944NIGMS NIH HHS R01GM36944-22
6 · The paper itself

Abstract

The cleavage rates of 78 hammerhead ribozymes containing structurally conservative chemical modifications were collected from the literature and compared to the recently determined crystal structure of the Schistosoma mansoni hammerhead. With only a few exceptions, the biochemical data were consistent with the structure, indicating that the new structure closely resembles the transition state of the reaction. Since all the biochemical data were collected on minimal hammerheads that have a very different structure, the minimal hammerhead must be dynamic and occasionally adopt the quite different extended structure in order to cleave.

Indexed as

AnimalsCatalytic DomainCrystallography, X-RayHydrogen BondingKineticsManganeseModels, MolecularNucleic Acid ConformationRNA, CatalyticRNA, HelminthSchistosoma mansonihammerhead ribozymeManganeseRNA, CatalyticRNA, Helminth

Identifiers

PMID18287565
PMCPMC2271363
OpenAlexW2119718783

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.